Shortening antibiotic duration in the treatment of acute cholangitis due to choledocholitiasis with successful biliary duct drainage
1
surgery, St.Paraskeva medical center, Ukraine
2
Anaesthesiology and Intensive Care, Communal Municipal Clinical Hospital 8, Ukraine
3
Surgery, Zaycev V.T. “Institute of general and emergency surgery of the national academy of medical sciences of Ukraine, Ukraine
4
Surgery, Bukovinian State Medical University, Ukraine
Submission date: 2025-01-01
Final revision date: 2025-07-11
Acceptance date: 2025-08-28
Publication date: 2025-12-30
Wiadomości Lekarskie 2025;(12):2735-2741
KEYWORDS
TOPICS
ABSTRACT
Aim:
The optimal duration of antimicrobial treatment in common bile duct stone associated cholangitis is not well established. We aimed to evaluate the efficacy and safety of short duration vs 14-day antibiotic therapy in acute cholangitis associated with common bile duct stone.
Material and methods:
We divided 278 patients with all stages of acute cholangitis who underwent technically successful ERCP from January 2019 to June 2023 and had positive bile cultures into two groups: antibiotic therapy within two days of ERCP (short-course therapy, SCT; n = 48), and for >3 days (long-course therapy, LCT; n = 230).
Results:
Three recurrence occurred in STC and one recurrence occurred in LTC (p = 0.19). Clinical outcomes were similar between the two groups. The fever duration was similar between mild and moderate cholangitis within the same group and between the 2 groups. Duration of antibiotic therapy in LTC was 4.22 + 1.37 days with 39 (81.3%) needing treatment for < 5 days.
Conclusions:
Short duration antibiotic treatment based on fever resolution of 72 hours was effective and safe in patients with mild to moderate cholangitis due to common bile duct stone.
The optimal duration of antimicrobial treatment in common bile duct stone associated cholangitis is not well established. We aimed to evaluate the efficacy and safety of short duration vs 14-day antibiotic therapy in acute cholangitis associated with common bile duct stone.
Material and methods:
We divided 278 patients with all stages of acute cholangitis who underwent technically successful ERCP from January 2019 to June 2023 and had positive bile cultures into two groups: antibiotic therapy within two days of ERCP (short-course therapy, SCT; n = 48), and for >3 days (long-course therapy, LCT; n = 230).
Results:
Three recurrence occurred in STC and one recurrence occurred in LTC (p = 0.19). Clinical outcomes were similar between the two groups. The fever duration was similar between mild and moderate cholangitis within the same group and between the 2 groups. Duration of antibiotic therapy in LTC was 4.22 + 1.37 days with 39 (81.3%) needing treatment for < 5 days.
Conclusions:
Short duration antibiotic treatment based on fever resolution of 72 hours was effective and safe in patients with mild to moderate cholangitis due to common bile duct stone.
Share
RELATED ARTICLE
| eISSN: | 2719-342X |
| ISSN: | 0043-5147 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
